SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?


To: sim1 who wrote (1629)6/25/2003 10:30:09 PM
From: Roger Folsom  Read Replies (1) | Respond to of 1728
 
For Affymetrix, the Roche news appears to be good, perhaps very good. So why did AFFX decline today, to below $20 ($19.99)?

I'd be interested in any information (or informed gossip, for that matter), other than already included in Tuck's post (1628) and Silen's post (1629) about the "partnership" (if that is the word) between AFFX and Roche.

Roger Folsom